XML 19 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1
Earnings Per Share
9 Months Ended
Oct. 28, 2017
Earnings Per Share [Abstract]  
Earnings Per Share
Note 4
Earnings Per Share
 
The Company uses the two-class method to compute basic and diluted earnings per common share attributable to Caleres, Inc. shareholders. In periods of net loss, no effect is given to the Company’s participating securities since they do not contractually participate in the losses of the Company. The following table sets forth the computation of basic and diluted earnings per common share attributable to Caleres, Inc. shareholders for the periods ended October 28, 2017 and October 29, 2016:
 
 
Thirteen Weeks Ended
Thirty-Nine Weeks Ended
($ thousands, except per share amounts)
October 28, 2017

October 29, 2016

October 28, 2017

October 29, 2016

NUMERATOR
 

 

 

 

Net earnings
$
34,373

$
34,726

$
66,931

$
72,282

Net loss (earnings) attributable to noncontrolling interests
14

4

(47
)
(2
)
Net earnings allocated to participating securities
(949
)
(910
)
(1,841
)
(1,933
)
Net earnings attributable to Caleres, Inc. after allocation of earnings to participating securities
$
33,438

$
33,820

$
65,043

$
70,347

 
 
 
 
 
DENOMINATOR
 

 

 

 

Denominator for basic earnings per common share attributable to Caleres, Inc. shareholders
41,788

41,802

41,801

42,093

Dilutive effect of share-based awards
182

137

173

144

Denominator for diluted earnings per common share attributable to Caleres, Inc. shareholders
41,970

41,939

41,974

42,237

 
 
 
 
 
Basic earnings per common share attributable to Caleres, Inc. shareholders
$
0.80

$
0.81

$
1.56

$
1.67

 
 
 
 
 
Diluted earnings per common share attributable to Caleres, Inc. shareholders
$
0.80

$
0.81

$
1.55

$
1.67


 
Options to purchase 16,667 shares of common stock for the thirteen and thirty-nine weeks ended October 28, 2017 and 63,915 shares of common stock for the thirteen and thirty-nine weeks ended October 29, 2016 were not included in the denominator for diluted earnings per common share attributable to Caleres, Inc. shareholders because the effect would be anti-dilutive.

During the thirteen and thirty-nine weeks ended October 28, 2017, the Company repurchased zero and 225,000 shares, respectively, under the publicly announced share repurchase program, which permits repurchases of up to 2.5 million shares. The Company repurchased zero and 900,000 shares during the thirteen and thirty-nine weeks ended October 29, 2016, respectively. As of October 28, 2017, the Company has repurchased a total of 1.3 million shares under this program.